Complete Filing Data
Ribbon Acquisition Corp. reported Stockholders Equity of -$344.3 thousand for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ribbon Acquisition Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | $690.2K |
| Operating Income Loss | -$1.3M |
| Operating Expenses | $1.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Net Income Loss | $62.1K | $271.3K | $235.9K | -$10.3K |
| Operating Income Loss | -$463.7K | -$242.9K | -$185.4K | -$10.3K |
| Operating Expenses | $463.7K | $242.9K | $185.4K | $10.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | -$344.3K | $14.7K |
| Retained Earnings Accumulated Deficit | -$344.5K | -$10.3K |
| Liabilities Current | $607.0K | $494.0K |
| Liabilities And Stockholders Equity | $52.0M | $508.7K |
| Assets | $52.0M | $508.7K |
| Accrued Liabilities Current | $192.0K | $229.0K |
| Liabilities | $2.6M | $494.0K |
| Assets Current | $50.8K | $508.7K |
| Additional Paid In Capital Common Stock | $24.9K | |
| Temporary Equity Accretion To Redemption Value | $5.9M | |
| Deferred Offering Costs Paid By Sponsor Under The Promissory Noterelated Party | $10.0K | |
| Deferred Offering Costs Included In Accrued Offerings Costs And Expenses | $9.0K | |
| Deferred Costs Current | $508.7K | |
| Deferred Underwriting Commission Non Current | $2.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $11.5K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.5K | |
| Cash And Cash Equivalents At Carrying Value | $11.5K | |
| Assets Held In Trust Noncurrent | $51.9M | |
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | ||
| Repayments Of Notes Payable | $274.9K | |
| Accounts Payable Other Current | $415.0K | |
| Temporary Equity Accretion To Redemption Value Adjustment |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Stockholders Equity | $1.1M | $2.5M | $3.8M | $14.7K |
| Retained Earnings Accumulated Deficit | $559.0K | $496.8K | $225.6K | |
| Liabilities Current | $309.0K | $78.0K | $78.5K | |
| Liabilities And Stockholders Equity | $51.6M | $51.3M | $51.0M | |
| Assets | $51.6M | $51.3M | $51.0M | |
| Accrued Liabilities Current | $108.0K | $78.0K | $78.5K | |
| Liabilities | $2.3M | $2.1M | $2.1M | |
| Assets Current | $118.9K | $351.6K | $595.0K | |
| Additional Paid In Capital Common Stock | $507.5K | $2.0M | $3.6M | |
| Temporary Equity Accretion To Redemption Value | $1.5M | $1.5M | $1.3M | |
| Deferred Offering Costs Paid By Sponsor Under The Promissory Noterelated Party | $10.0K | $258.8K | ||
| Deferred Offering Costs Included In Accrued Offerings Costs And Expenses | $9.0K | |||
| Deferred Costs Current | ||||
| Deferred Underwriting Commission Non Current | $2.0M | $2.0M | $2.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $536.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $59.9K | $292.6K | $536.0K | |
| Cash And Cash Equivalents At Carrying Value | $59.9K | $292.6K | $536.0K | |
| Assets Held In Trust Noncurrent | $51.5M | $50.9M | $50.4M | |
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares | 25.0K | |||
| Repayments Of Notes Payable | ||||
| Accounts Payable Other Current | $200.0K | |||
| Temporary Equity Accretion To Redemption Value Adjustment | $1.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Proceeds From Issuance Of Common Stock | $2.2M |
| Proceeds From Issuance Initial Public Offering | $49.0M |
| Payments To Acquire Marketable Securities | $50.0M |
| Payments Of Stock Issuance Costs | $214.1K |
| Net Cash Provided By Used In Operating Activities | -$699.4K |
| Net Cash Provided By Used In Investing Activities | -$50.0M |
| Net Cash Provided By Used In Financing Activities | $50.7M |
| Increase Decrease In Prepaid Expense | $39.3K |
| Increase Decrease In Accrued Liabilities | $183.0K |
| Proceeds From Repayments Of Notes Payable | |
| Increase Decrease In Other Accounts Payable | $415.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 |
|---|---|---|
| Proceeds From Issuance Of Common Stock | $2.2M | |
| Proceeds From Issuance Initial Public Offering | $49.0M | |
| Payments To Acquire Marketable Securities | $50.0M | |
| Payments Of Stock Issuance Costs | $214.1K | |
| Net Cash Provided By Used In Operating Activities | -$174.9K | |
| Net Cash Provided By Used In Investing Activities | -$50.0M | |
| Net Cash Provided By Used In Financing Activities | $50.7M | |
| Increase Decrease In Prepaid Expense | -$8.5K | |
| Increase Decrease In Accrued Liabilities | $1.8K | |
| Proceeds From Repayments Of Notes Payable | -$274.9K | |
| Increase Decrease In Other Accounts Payable |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Administrative Fees Expense | $1.3M |
| Investment Income Interest | $1.9M |
| Stock Issued During Period Value Sale Of Private Placement Units | $2.2M |
| Prepaid Expense Current | $39.3K |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $2.6M |
| Stock Issued During Period Value New Issues | |
| Issuance Of Public Rights Net Of Issuance Costs | |
| Accretion Of Ordinary Shares Subject To Redemption Value | 5.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Administrative Fees Expense | $463.7K | $242.9K | $185.4K | $10.3K |
| Investment Income Interest | $525.9K | $514.2K | $421.3K | |
| Stock Issued During Period Value Sale Of Private Placement Units | $2.2M | |||
| Prepaid Expense Current | $59.0K | $59.0K | $59.0K | |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $2.6M | |||
| Stock Issued During Period Value New Issues | $25.0K | |||
| Issuance Of Public Rights Net Of Issuance Costs | $2.6M | |||
| Accretion Of Ordinary Shares Subject To Redemption Value |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.